144 related articles for article (PubMed ID: 30971932)
1. Glial Growth Factor 2 Regulates Glucose Transport in Healthy Cardiac Myocytes and During Myocardial Infarction via an Akt-Dependent Pathway.
Shoop S; Maria Z; Campolo A; Rashdan N; Martin D; Lovern P; Lacombe VA
Front Physiol; 2019; 10():189. PubMed ID: 30971932
[TBL] [Abstract][Full Text] [Related]
2. Intravenous glial growth factor 2 (GGF2) isoform of neuregulin-1β improves left ventricular function, gene and protein expression in rats after myocardial infarction.
Hill MF; Patel AV; Murphy A; Smith HM; Galindo CL; Pentassuglia L; Peng X; Lenneman CG; Odiete O; Friedman DB; Kronenberg MW; Zheng S; Zhao Z; Song Y; Harrell FE; Srinivas M; Ganguly A; Iaci J; Parry TJ; Caggiano AO; Sawyer DB
PLoS One; 2013; 8(2):e55741. PubMed ID: 23437060
[TBL] [Abstract][Full Text] [Related]
3. Neuregulin-1 triggers GLUT4 translocation and enhances glucose uptake independently of insulin receptor substrate and ErbB3 in neonatal rat cardiomyocytes.
Heim P; Morandi C; Brouwer GR; Xu L; Montessuit C; Brink M
Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118562. PubMed ID: 31669265
[TBL] [Abstract][Full Text] [Related]
4. Anti-remodeling and anti-fibrotic effects of the neuregulin-1β glial growth factor 2 in a large animal model of heart failure.
Galindo CL; Kasasbeh E; Murphy A; Ryzhov S; Lenihan S; Ahmad FA; Williams P; Nunnally A; Adcock J; Song Y; Harrell FE; Tran TL; Parry TJ; Iaci J; Ganguly A; Feoktistov I; Stephenson MK; Caggiano AO; Sawyer DB; Cleator JH
J Am Heart Assoc; 2014 Oct; 3(5):e000773. PubMed ID: 25341890
[TBL] [Abstract][Full Text] [Related]
5. Diabetes Alters the Expression and Translocation of the Insulin-Sensitive Glucose Transporters 4 and 8 in the Atria.
Maria Z; Campolo AR; Lacombe VA
PLoS One; 2015; 10(12):e0146033. PubMed ID: 26720696
[TBL] [Abstract][Full Text] [Related]
6. Effects of neuregulin GGF2 (cimaglermin alfa) dose and treatment frequency on left ventricular function in rats following myocardial infarction.
Parry TJ; Ganguly A; Troy EL; Luis Guerrero J; Iaci JF; Srinivas M; Vecchione AM; Button DC; Hackett CS; Zolty R; Sawyer DB; Caggiano AO
Eur J Pharmacol; 2017 Feb; 796():76-89. PubMed ID: 27993643
[TBL] [Abstract][Full Text] [Related]
7. Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt.
Fukazawa R; Miller TA; Kuramochi Y; Frantz S; Kim YD; Marchionni MA; Kelly RA; Sawyer DB
J Mol Cell Cardiol; 2003 Dec; 35(12):1473-9. PubMed ID: 14654373
[TBL] [Abstract][Full Text] [Related]
8. Neuregulin-1β promotes glucose uptake via PI3K/Akt in neonatal rat cardiomyocytes.
Pentassuglia L; Heim P; Lebboukh S; Morandi C; Xu L; Brink M
Am J Physiol Endocrinol Metab; 2016 May; 310(9):E782-94. PubMed ID: 26979522
[TBL] [Abstract][Full Text] [Related]
9. Sarcoplasmic reticulum Ca2+ ATPase pump is a major regulator of glucose transport in the healthy and diabetic heart.
Waller AP; Kalyanasundaram A; Hayes S; Periasamy M; Lacombe VA
Biochim Biophys Acta; 2015 May; 1852(5):873-81. PubMed ID: 25615793
[TBL] [Abstract][Full Text] [Related]
10. Chronic Neuregulin-1β Treatment Mitigates the Progression of Postmyocardial Infarction Heart Failure in the Setting of Type 1 Diabetes Mellitus by Suppressing Myocardial Apoptosis, Fibrosis, and Key Oxidant-Producing Enzymes.
Gupte M; Lal H; Ahmad F; Sawyer DB; Hill MF
J Card Fail; 2017 Dec; 23(12):887-899. PubMed ID: 28870731
[TBL] [Abstract][Full Text] [Related]
11. Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction.
Karwi QG; Zhang L; Wagg CS; Wang W; Ghandi M; Thai D; Yan H; Ussher JR; Oudit GY; Lopaschuk GD
Cardiovasc Diabetol; 2019 Jan; 18(1):1. PubMed ID: 30626440
[TBL] [Abstract][Full Text] [Related]
12. ERBB signaling attenuates proinflammatory activation of nonclassical monocytes.
Ryzhov S; Matafonov A; Galindo CL; Zhang Q; Tran TL; Lenihan DJ; Lenneman CG; Feoktistov I; Sawyer DB
Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H907-H918. PubMed ID: 28235789
[TBL] [Abstract][Full Text] [Related]
13. Activation of AMPK alleviates cardiopulmonary bypass-induced cardiac injury via ameliorating acute cardiac glucose metabolic disorder.
Wang Z; Cao Y; Yin Q; Han Y; Wang Y; Sun G; Zhu H; Xu M; Gu C
Cardiovasc Ther; 2018 Dec; 36(6):e12482. PubMed ID: 30632675
[TBL] [Abstract][Full Text] [Related]
14. The Rab GTPase-activating protein AS160 integrates Akt, protein kinase C, and AMP-activated protein kinase signals regulating GLUT4 traffic.
Thong FS; Bilan PJ; Klip A
Diabetes; 2007 Feb; 56(2):414-23. PubMed ID: 17259386
[TBL] [Abstract][Full Text] [Related]
15. Catestatin Induces Glucose Uptake and GLUT4 Trafficking in Adult Rat Cardiomyocytes.
Gallo MP; Femminò S; Antoniotti S; Querio G; Alloatti G; Levi R
Biomed Res Int; 2018; 2018():2086109. PubMed ID: 30370303
[TBL] [Abstract][Full Text] [Related]
16. PEDF increases GLUT4-mediated glucose uptake in rat ischemic myocardium via PI3K/AKT pathway in a PEDFR-dependent manner.
Yuan Y; Liu X; Miao H; Huang B; Liu Z; Chen J; Quan X; Zhu L; Dong H; Zhang Z
Int J Cardiol; 2019 May; 283():136-143. PubMed ID: 30819588
[TBL] [Abstract][Full Text] [Related]
17. Neuregulin-1 preconditioning protects the heart against ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
Fang SJ; Wu XS; Han ZH; Zhang XX; Wang CM; Li XY; Lu LQ; Zhang JL
Chin Med J (Engl); 2010 Dec; 123(24):3597-604. PubMed ID: 22166638
[TBL] [Abstract][Full Text] [Related]
18. 5'-AMP-activated protein kinase increases glucose uptake independent of GLUT4 translocation in cardiac myocytes.
Lee CT; Ussher JR; Mohammad A; Lam A; Lopaschuk GD
Can J Physiol Pharmacol; 2014 Apr; 92(4):307-14. PubMed ID: 24708213
[TBL] [Abstract][Full Text] [Related]
19. Insulin protects isolated hearts from ischemia/reperfusion injury: cross-talk between PI3-K/Akt and JNKs.
Liu HT; Zhang HF; Si R; Zhang QJ; Zhang KR; Guo WY; Wang HC; Gao F
Sheng Li Xue Bao; 2007 Oct; 59(5):651-9. PubMed ID: 17940706
[TBL] [Abstract][Full Text] [Related]
20. Impaired stimulation of glucose transport in cardiac myocytes exposed to very low-density lipoproteins.
Papageorgiou I; Viglino C; Brulhart-Meynet MC; James RW; Lerch R; Montessuit C
Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):614-622. PubMed ID: 27052924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
